… of vascular stiffness), cIMT, or VC. This study does not lend support for further study of
phosphate binders in early-stage CKD because of the failure to affect phosphate homeostasis. A …

… the effect of the phosphate binder lanthanum carbonate on intermediate cardiovascular …
It is upregulated from an early stage of CKD and is an important biomarker in CKD-MBD. …

… kidney function, and … of effect of phosphate binders on cardiovascular intermediate markers
in our study was consistent with an open-labeled clinical trial, which randomized 120 patients …

… Phosphate binders are prescribed to chronic kidney disease (CKD) patients based on
associations of serum phosphate … Null effects of phosphate binders on these hormones may reflect …

… oral, non-calcium-based phosphate binder, are assessed in a … trial of 120 patients with stage
3 chronic kidney disease. … the burden of cardiovascular disease caused by early stage CKD, …

… Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney
disease… calcium-based phosphate binders in patients with chronic kidney disease: a systematic …

… trials that have investigated the impact of phosphate binders in CKD patients. The aim of
the … view on the phosphate binder use in non-dialysis dependent CKD patients (NDD-CKD). …

… In conclusion, many studies showed that lanthanum carbonate has similar clinical adverse
effects with other phosphate binders, arising mostly from GI tract. Studies in humans did not …

… those with cardiovascular disease, but normal kidney function, … effects on PWV between
the noncalcium phosphate binder … phosphate binders also had uncertain effects on vascular …

… The non-calcium-containing phosphate binder sevelamer has been linked to slowing the …
We demonstrated its beneficial effect for arterial stiffness parameters in dialysis patients …